Caris Life Sciences, Inc.

CAI · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2020
Assets
Cash & Equivalents$63,950$56,402$107,191$53,547
Short-Term Investments$2,201$65,184$302,433$78,992
Receivables$88,244$55,299$40,227$144,302
Inventory$39,572$48,998$46,956$0
Other Curr. Assets$21,762$16,729$19,237-$62,179
Total Curr. Assets$215,729$242,612$516,044$214,662
Property Plant & Equip (Net)$102,767$147,514$138,049$1,781,321
Goodwill$19,344$19,344$19,344$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$5,894$3,430$43,985$616,649
Total NC Assets$128,005$170,288$201,378$2,397,970
Other Assets$0$0$0$0
Total Assets$343,734$412,900$717,422$2,612,632
Liabilities
Payables$27,791$26,680$27,269$3,666
Short-Term Debt$66,170$6,754$57,093$183,448
Tax Payable$0$0$0$0
Deferred Revenue$7,470$5,676$1,434$3,029
Other Curr. Liab.$63,992$56,028$51,110$130,107
Total Curr. Liab.$165,423$95,138$136,906$320,250
LT Debt$358,089$210,520$213,779$1,562,283
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$24,442
Other NC Liab.$2,319,060$2,252,192$2,068,850$3,417
Total NC Liab.$2,677,149$2,462,712$2,282,629$1,590,142
Other Liabilities$0$0$0$0
Cap. Leases$45,064$51,001$48,509$0
Total Liabilities$2,842,572$2,557,850$2,419,535$1,910,392
Equity
Pref Stock$0$0$0$103,865
Common Stock$38$38$138$2
Retained Earnings-$2,472,300-$2,119,175-$1,678,650$503,321
AOCI$210$218$1,698-$5,743
Other Equity-$26,786-$26,031-$25,299$100,795
Total Equity-$2,498,838-$2,144,950-$1,702,113$702,240
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$343,734$412,900$717,422$2,612,632
Net Debt$360,309$160,872$163,681$1,692,184